Cronos Group Launches Premium Lord Jones(TM) Brand in Israel, Advancing Borderless Product Strategy

Executive Summary

• Cronos Group announced the launch of its premium Lord Jones® cannabis brand in Israel, marking the first phase of entry into the Israeli medical market.
• The initial offering includes five indoor‑grown flower strains that will be sold through pharmacies across Israel.
• The company highlighted its disciplined “borderless product strategy” and indicated plans for future special‑edition and limited‑run Lord Jones® products in the region.

Key Details

• Launch of Lord Jones® premium cannabis brand in Israel, expanding Cronos’ international portfolio.
• First phase delivers five premium indoor‑grown flower strains to Israeli medical patients.
• Products are cultivated in small batches, cold‑cured, hand‑trimmed, and packaged in glass jars to preserve terpene richness and quality.
• Availability begins immediately in pharmacies throughout Israel.
• Cronos plans future special‑edition and limited‑run Lord Jones® products for the Israeli market.
• CEO Mike Gorenstein emphasized the launch as a key milestone in the company’s “borderless product strategy.”
• General Manager Adam Wagner highlighted rigorous oversight from genetics to packaging, reinforcing premium quality standards.

Notable Quotes

“Israel has always represented a key market in our borderless product strategy,” said Mike Gorenstein, Chairman, President and CEO of Cronos.

“The launch of the Lord Jones® brand in Israel marks an important milestone for us, bringing a premium standard to the Israeli medical market…” – Adam Wagner, General Manager of Cronos Israel.